Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
Condition: Thyroid Nodule, Toxic or With Hyperthyroidism · Autonomous Thyroid Function · Thyroid Nodule; Hyperthyroidism · Sponsor: Rijnstate Hospital
About this study
The purpose of this study is to compare treatment of hyperthyroidism with radiofrequency ablation or I-131 for solitary autonomous thyroid nodules.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (14)
| Ziekenhuis Groep Twente | Almelo, Gelderland, Netherlands | — |
| Gelre Hospitals | Apeldoorn, Gelderland, Netherlands | — |
| Rijnstate Hospital | Arnhem, Gelderland, Netherlands | — |
| Laurentius Hospital | Roermond, Limburg, Netherlands | — |
| Amphia Hospital | Breda, North Brabant, Netherlands | — |
| Catharina Hospital | Eindhoven, North Brabant, Netherlands | — |
| Elkerliek Hospital | Helmond, North Brabant, Netherlands | — |
| Amsterdam UMC, location VUMC | Amsterdam, North Holland, Netherlands | — |
| OLVG | Amsterdam, North Holland, Netherlands | — |
| Spaarne Gasthuis | Hoofddorp, North Holland, Netherlands | — |
| Albert Schweiter Hospital | Dordrecht, South Holland, Netherlands | — |
| Haaglanden MC | The Hague, South Holland, Netherlands | — |
+ 2 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05142904